Lipophilicity of flavonoid complexes with iron(II) and their interaction with liposomes

Biochemical and Biophysical Research Communications

Volumn 431, Issue 4, 2013, Pages 680-685

  Kim, Yuri A ^a   Tarahovsky, Yury S ^b,c   Yagolnik, Elena A ^d   Kuznetsova, Svetlana M ^b   Muzafarov, Eugeny N ^d,e  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^b INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^c MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^d TULA STATE UNIVERSITY   (Russian Federation)

^e INSTITUTE OF BASIC BIOLOGICAL PROBLEMS   (Russian Federation)

Author keywords

Flavonoids; Iron chelators; Lipid phase transitions; Liposomes; Quercetin; Taxifolin

Indexed keywords

FERROUS ION; LIPOSOME; PHOSPHATIDYLETHANOLAMINE; QUERCETIN; TAXIFOLIN;

ARTICLE; BIOAVAILABILITY; CELL MEMBRANE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; LIPOPHILICITY; MOLECULAR MODEL; PARTITION COEFFICIENT; PHASE TRANSITION; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; STOICHIOMETRY; ULTRAVIOLET SPECTROSCOPY;

FLAVONOIDS; IRON; LIPOSOMES; MODELS, MOLECULAR; OCTANOLS; PHOSPHATIDYLETHANOLAMINES; QUERCETIN; SPECTROPHOTOMETRY, ULTRAVIOLET; WATER;

EID: 84875253240     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.060     Document Type: Article

References (43)

1. Prasain J.K., Carlson S.H., Wyss J.M. Flavonoids and age-related disease: risk, benefits and critical windows. Maturitas 2010, 66:163-171.
2. Malesev D., Kuntic V. Investigation of metal-flavonoid chelates and the determination of flavonoids via metal-flavonoid complexing reactions. J. Serb. Chem. Soc. 2007, 72:921-939.
3. Pereira R.M., Andrades N.E., Paulino N., Sawaya A.C., Eberlin M.N., Marcucci M.C., Favero G.M., Novak E.M., Bydlowski S.P. Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial antiinflammatory and tumor cell cytotoxicity. Molecules 2007, 12:1352-1366.
4. Ren J., Meng S., Lekka C., Kaxiras E. Complexation of flavonoids with iron: structure and optical signatures. J. Phys. Chem. B 2008, 112:1845-1850.
5. Kostyuk V.A., Potapovich A.I., Strigunova E.N., Kostyuk T.V., Afanas'ev I.B. Experimental evidence that flavonoid metal complexes may act as mimics of superoxide dismutase. Arch. Biochem. Biophys. 2004, 428:204-208.
6. Cohen G., Riahi Y., Sasson S. Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues. Arch. Physiol. Biochem. 2011, 117:131-139.
7. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F., Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med. 1995, 19:481-486.
8. Klopman G., Zhu H. Recent methodologies for the estimation of n-octanol/water partition coefficients and their use in the prediction of membrane transport properties of drugs. Mini-Rev. Med. Chem. 2005, 5:127-133.
9. Tarahovsky Y.S., Yagolnik E.A., Muzafarov E.N., Abdrasilov B.S., Kim Y.A. Calcium-dependent aggregation and fusion of phosphatidylcholine liposomes induced by complexes of flavonoids with divalent iron. Biochim. Biophys. Acta 1818, 2012:695-702.
10. Fujita T., Iwasa J., Hansch C.A. New substituent constant, r{cyrillic}, derived from partition coefficients. J. Am. Chem. Soc. 1964, 86:5175-5180.
11. Sharma B.K. Instrumental Methods of Chemical Analysis 2005, GOEL Publishing House, Meerut.
12. Briciu R.D., Kot-Wasik A., Namiesnik J., Sarbu C. The lipophilicity indices of flavonoids estimated by reversed-phase liquid chromatography using different computation methods. J. Sep. Sci. 2009, 32:2066-2074.
13. Guo M., Perez C., Wei Y., Rapoza E., Su G., Bou-Abdallah F., Chasteen N.D. Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans. 2007, 4951-4961.
14. Foti M., Piattelli M., Baratta M.N., Ruberto G. Flavonoids, coumarins, and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship. J. Agric. Food Chem. 1996, 44:497-501.
15. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., Hirai M., Tsukahara G. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol. Pharm. Bull. 2005, 28:2274-2278.
16. Rothwell J.A., Day A.J., Morgan M.R. Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J. Agric. Food Chem. 2005, 53:4355-4360.
17. Wolfe K.L., Liu R.H. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay. J. Agric. Food Chem. 2008, 56:8404-8411.
18. Fossen T., Andersen O.M. Spectroscopic techniques applied to flavonoids. Flavonoids: Chemistry, Biochemistry and Applications 2006, 37-142. CRC Press, New York. O.M. Andersen, K.R. Markham (Eds.).
19. Singh D., Rawat M.S., Semalty A., Semalty M. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. Curr. Drug Discov. Technol. 2012, 9:17-24.
20. Goniotaki M., Hatziantoniou S., Dimas K., Wagner M., Demetzos C. Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines. J. Pharm. Pharmacol. 2004, 56:1217-1224.
21. Wesolowska O., Hendrich A.B., Laniapietrzak B., Wisniewski J., Molnar J., Ocsovszki I., Michalak K. Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids. Cell Mol. Biol. Lett. 2009, 14:199-221.
22. Lazaro E., Castillo J.A., Rafols C., Roses M., Clapes P., Torres J.L. Interaction of antioxidant biobased epicatechin conjugates with biomembrane models. J. Agric. Food Chem. 2007, 55:2901-2905.
23. Caturla N., Vera-Samper E., Villalain J., Mateo C.R., Micol V. The relationship between the antioxidant and the antibacterial properties of galloylated catechins and the structure of phospholipid model membranes. Free Radic. Biol. Med. 2003, 34:648-662.
24. Tarahovsky Y.S., Muzafarov E.N., Kim Y.A. Rafts making and rafts braking: how plant flavonoids may control membrane heterogeneity. Mol. Cell Biochem. 2008, 314:65-71.
25. Kasvosve I., Delanghe J. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clin. Chem. Lab. Med. 2002, 40:1014-1018.
26. Rappolt M., Hodzic A., Sartori B., Ollivon M., Laggner P. Conformational and hydrational properties during the L(beta)- to L(alpha)- and L(alpha)- to H(II)-phase transition in phosphatidylethanolamine. Chem. Phys. Lipids 2008, 154:46-55.
27. Borovjagin V.L., Vergara J.A., McIntosh T.J. Morphology of the intermediate stages in the lamellar to hexagonal lipid phase transition. J. Membr. Biol. 1982, 69:199-212.
28. Tarahovsky Y.S. " Smart" liposomal nanocontainers in biology and medicine. Biochemistry (Moscow) 2010, 75:811-824.
29. Tarahovsky Y.S. Cell transfection by DNA-lipid complexes-lipoplexes. Biochemistry (Moscow) 2009, 74:1293-1304.
30. Chen Z.P., Sun J., Chen H.X., Xiao Y.Y., Liu D., Chen J., Cai H., Cai B.C. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 2010, 81:1045-1052.
31. Goldberg E.M., Zidovetzki R. Synergistic effects of diacylglycerols and fatty acids on membrane structure and protein kinase C activity. Biochemistry 1998, 37:5623-5632.
32. Barcelo F., Prades J., Encinar J.A., Funari S.S., Vogler O., Gonzalez-Ros J.M., Escriba P.V. Interaction of the C-terminal region of the G-gamma protein with model membranes. Biophys. J. 2007, 93:2530-2541.
33. Alemany R., Perona J.S., Sanchez-Dominguez J.M., Montero E., Canizares J., Bressani R., Escriba P.V., Ruiz-Gutierrez V. G protein-coupled receptor systems and their lipid environment in health disorders during aging. Biochim. Biophys. Acta 2007, 1768:964-975.
34. Lin A.H., Leung G.P., Leung S.W., Vanhoutte P.M., Man R.Y. Genistein enhances relaxation of the spontaneously hypertensive rat aorta by transactivation of epidermal growth factor receptor following binding to membrane estrogen receptors-alpha and activation of a G protein-coupled, endothelial nitric oxide synthase-dependent pathway. Pharmacol. Res. 2011, 63:181-189.
35. Lu J., Gosslau A., Liu A.Y., Chen K.Y. PCR differential display-based identification of regulator of G protein signaling 10 as the target gene in human colon cancer cells induced by black tea polyphenol theaflavin monogallate. Eur. J. Pharmacol. 2008, 601:66-72.
36. Jefremov V., Rakitin A., Mahlapuu R., Zilmer K., Bogdanovic N., Zilmer M., Karelson E. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens. J. Neuroendocrinol. 2008, 20:587-596.
37. Goumon Y., Angelone T., Schoentgen F., Chasserot-Golaz S., Almas B., Fukami M.M., Langley K., Welters I.D., Tota B., Aunis D., Metz-Boutigue M.H. The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J. Biol. Chem. 2004, 279:13054-13064.
38. Jammulamadaka N., Burgula S., Medisetty R., Ilavazhagan G., Rao S.L., Singh S.S. beta-N-oxalyl-L-alpha, beta-diaminopropionic acid regulates mitogen-activated protein kinase signaling by down-regulation of phosphatidylethanolamine-binding protein 1. J. Neurochem. 2011, 118:176-186.
39. Wang X., Wang S., Tang X., Zhang A., Grabinski T., Guo Z., Hudson E., Berghuis B., Webb C., Zhao P., Cao B. Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients. J. Immunol. Methods 2010, 362:151-160.
40. Zhang Y., Wang X., Xiang Z., Li H., Qiu J., Sun Q., Wan T., Li N., Cao X., Wang J. Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein. Int. J. Mol. Med. 2007, 19:55-63.
41. Wang X., Li N., Liu B., Sun H., Chen T., Li H., Qiu J., Zhang L., Wan T., Cao X. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization. J. Biol. Chem. 2004, 279:45855-45864.
42. Reumer A., Bogaerts A., Van Loy T., Husson S.J., Temmerman L., Choi C., Clynen E., Hassan B., Schoofs L. Unraveling the protective effect of a Drosophila phosphatidylethanolamine-binding protein upon bacterial infection by means of proteomics. Dev. Comp. Immunol. 2009, 33:1186-1195.
43. George A.J., Holsinger R.M., McLean C.A., Tan S.S., Scott H.S., Cardamone T., Cappai R., Masters C.L., Li Q.X. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Aging 2006, 27:614-623.